Can the Treatment Services Review be used to estimate the costs of addiction and ancillary services?

Journal of Substance Abuse

Volumn 12, Issue 4, 2000, Pages 341-361

  French, Michael T ^a   Roebuck, M Christopher ^a   McLellan, A Thomas ^b   Sindelar, Jody L ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Addiction; Cost; Service; Treatment; TSR

Indexed keywords

ADDICTION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HOSPITAL MANAGEMENT; HUMAN; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MEDICAL RESEARCH; PRIORITY JOURNAL; RELIABILITY; REVIEW; SOCIOECONOMICS; STANDARDIZATION; SUBSTANCE ABUSE; AMBULATORY CARE; ARTICLE; COST; ECONOMICS; HEALTH CARE; HOSPITAL ADMISSION; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PSYCHOTHERAPY; TREATMENT OUTCOME;

PSYCHOTROPIC AGENT;

AMBULATORY CARE; COMBINED MODALITY THERAPY; COMPREHENSIVE HEALTH CARE; COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; PATIENT CARE TEAM; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 0034570509     PISSN: 08993289     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3289(01)00058-X     Document Type: Article

References (34)

1. Hospital statistics. 1999;American Hospital Association, Chicago.
2. Medicare physician fee schedule. 1999;American Medical Association, Chicago.
3. Anderson D.W., Bowland B.J., Cartwright W.S., Bassin G. Service-level costing of drug abuse treatment. Journal of Substance Abuse Treatment. 15:1998;201-211.
4. Barnett P.G., Swindle R.W. Cost-effectiveness of inpatient substance abuse treatment. Health Services Research. 32(5):1997;615-629.
5. Draeger products: gas detection instruments. www.bgiusa.com/draeger/ gdi_br.htm:1999;. August 24.
6. Methadone and LAAM. 1996;Capital Consulting, Fairfax.
7. Administration manual for the Treatment Services Review (TSR), version 5. 1998;University of Pennsylvania, Philadelphia.
8. Drummond M.F., O'Brien B.J., Stoddart G.L., Torrance G.W. Methods for the economic evaluation of health care programmes. 2nd ed. 1997;Oxford Univ. Press, New York.
9. Finkler S.A. The distinction between cost and charges. Annals of Internal Medicine. 96:1982;102-109.
10. French M.T. Economic evaluation of alcohol treatment services. Evaluation and Program Planning. 23(1):2000;27-39.
11. French M.T. Drug Abuse Treatment Cost Analysis Program (DATCAP): program version user's manual. 7th ed. 2001;University of Miami, Coral Gables, FL.
12. French M.T. Drug Abuse Treatment Cost Analysis Program (DATCAP): program version. 7th ed. 2001;University of Miami, Coral Gables, FL.
13. French M.T., Dunlap L.J., Galinis D.N., Rachal J.V., Zarkin G.A. Health care reforms and managed care for substance abuse services: findings from 11 case studies. Journal of Public Health Policy. 17(2):1996;181-203.
14. French M.T., Dunlap L.J., Zarkin G.A., McGeary K.A., McLellan A.T. A structured instrument for estimating the economic cost of drug abuse treatment: the Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment. 14(4):1997;1-11.
15. French M.T., McCollister K.E., Cacciola J., McLellan A.T., Durell J. Benefit-cost analysis of addiction treatment in Arkansas: comparison of specialty and standard residential programs for pregnant and parenting women. 2000;University of Miami, Coral Gables, FL. Working paper.
16. French M.T., McCollister K.E., Sacks S., McKendrick K., DeLeon G. Benefit-cost analysis of a modified therapeutic community for mentally ill chemical abusers. 2000;University of Miami, Coral Gables, FL. Working paper.
17. French M.T., McGeary K.A. Estimating the economic cost of substance abuse treatment. Health Economics. 6:1997;539-544.
18. French M.T., Salomé H.J., Carney M. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the state of Washington. 2001;University of Miami, Coral Gables, FL. Working paper.
19. French M.T., Salomé H.J., Krupski A., McKay J.R., Donovan D.M., McLellan A.T., Durell J. Benefit-cost analysis of residential and outpatient addiction treatment in the state of Washington. Evaluation Review. 24(6):2000;609-634.
20. French, M. T., Salomé, H. J., Sindelar, J. L., & McLellan, A. T. Benefit-cost analysis of addiction treatment: methodological guidelines and application using the DATCAP and ASI. Health Services Research, forthcoming.
21. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine. 1996;Oxford Univ. Press, New York.
22. Humphreys K., Moos R.H. Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services. 47(7):1996;709-713.
23. Occupational employment statistics wage data. State of Illinois, Chicago, IL. http://www.ides.state.il.us:2000.
24. Rates for services billed to Medicaid or contracted. 2000;Office of Alcohol and Substance Abuse, Chicago.
25. McLellan A.T. An improved diagnostic evaluation instrument for substance abuse patients. Journal of Nervous and Mental Disease. 168:1980;26-33.
26. McLellan A.T., Alterman A.I., Cacciola J., Metzger D., O'Brien C.P. A new measure of substance abuse treatment: initial studies of the Treatment Services Review. Journal of Nervous and Mental Disease. 180:1992;101-110.
27. Drug topics red book. 1998;Medical Economics, Montvale.
28. http://www.medtox.com:2000.
29. Bringing drug abuse treatment from research to practice RFA: DA-99-007. 1999;U.S. Government Printing Office, Washington.
30. Salomé, H. J., & French, M. T. Using cost and financing instruments for economic evaluation of substance abuse treatment services. In M. Galanter (Ed.), Recent developments in alcoholism: vol. XIV. Services research in the era of managed care, Section 3. New York, NY: Kluwer Academic Publishing/Plenum, forthcoming.
31. Sindelar J.L., Jofre-Bonet M., French M.T., McLellan A.T. Cost-effectiveness analysis of treatment for illicit drug dependence: paradoxes with multivariate outcomes. 2000;Yale University, New Haven. Working paper.
32. Sloan F.A. Valuing health care. 1996;Cambridge Univ. Press, New York.
33. An evaluation of contracts between managed care organizations and community mental health and substance abuse treatment and prevention agencies. http:\\www.samhsa.gov:80/mc/mcrpt/mco_care/mco-back.htm:1997;. August 24.
34. Consumer price index, 1999. 2000;U.S. Government Printing Office, Washington.